Adapted HOPE workshop to reduce burnout for gynecologic oncology clinicians
Official title: Adaptation of Helping Ovarian Cancer Patients Cope (HOPE) for Clinician Burnout (HOPE-C)
Run by Fred Hutchinson Cancer Center · NCT07282158 · Data updated 2026-11-12
This program will test whether an adapted HOPE workshop can help gynecologic oncology clinicians reduce stress and burnout.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 25 (estimated) |
| Sponsor | Fred Hutchinson Cancer Center Academic / other |
| Locations | 1 site (Seattle, Washington) |
| Status | Recruiting |
| Started | February 24, 2026 |
| Main results expected | December 31, 2029 |
| Study ends | December 31, 2029 |
| Registry record updated | June 17, 2026 |
| Trial ID | NCT07282158 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal participants are English-speaking clinicians aged 18 or older who work with ovarian cancer patients (gynecologic oncologists, medical oncologists, nurses, social workers, and advanced practice providers) and can provide informed consent.
✕Probably not a fit
Clinicians who do not work with ovarian cancer patients, who cannot participate in brief weekly sessions, or who are non-English speakers may not receive benefit from this intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The protocol adapts the Helping Ovarian Cancer Patients Cope (HOPE) workshop for clinicians, focusing on narrative reframing, peer support, and meaning-making. Clinicians first review intervention materials and provide feedback via interviews and questionnaires during a development phase. A pilot phase has participants attend four weekly 30–45 minute HOPE-C sessions and complete questionnaires before and after the sessions. Participants may also be interviewed after completing the intervention to gather qualitative feedback.
Why it matters
Potential benefit: If successful, the intervention could lower clinician burnout and improve well-being, which may indirectly improve patient care and reduce errors.
How similar studies have gone: The original HOPE workshop has shown positive effects on hope and coping in ovarian cancer patients, and narrative or peer-support approaches have shown some success reducing clinician burnout, but applying HOPE to clinicians is a novel adaptation with limited prior testing.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age 18 years of age or older * English speaking * Able to provide informed consent * Working with patients with ovarian cancer (gynecologic oncologists, medical oncologists, nurses, social workers, and advance practice providers \[APPs\])
Where it's running
-
Fred Hutch/University of Washington Cancer Consortium
Seattle, Washington, United States Recruiting
Study contacts
- Principal investigator: Megan J. Shen, PhD — Fred Hutch/University of Washington Cancer Consortium
- Study coordinator: Megan J. Shen, PhD
- Email: mshen2@fredhutch.org
- Phone: 206-667-4172
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
High BMI and periodontitis in Thai adults under 60
This study tests how common high BMI and periodontitis are among Thai adults aged 18–59 and what factors are linked to them.
-
Blended e-Health Program to Help Women with Breast or Gynecologic Cancer Manage Fear of Cancer Progression
This trial tests a blended online and group program to see if it helps women with breast or gynecologic cancer feel less fear that their cancer could grow or spread.
-
Brief Suicidal Crisis Prevalence in Psychiatric Settings
This observational study tests how common a brief suicidal crisis (under 24 hours) is among adults seen by psychiatrists in Clermont-Ferrand, France.
-
Brief Case Management to Help Personal Recovery after Involuntary Psychiatric Admission
This trial tests whether a Brief Case Management approach helps people who were involuntarily admitted to a psychiatric hospital recover personally and avoid another involuntary readmission.
-
IGFBP-2 vaccine after platinum to slow ovarian cancer recurrence
This study tests whether giving an IGFBP-2 vaccine after one carboplatin dose can help prevent progression of ovarian, fallopian tube, or primary peritoneal cancer that has shown serologic recurrence.
-
Sailing to support psychosocial rehabilitation
This project tries sailing activities alongside usual care to see if they help adults with psychiatric or neurodevelopmental disorders who live in Seine-Saint-Denis.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.